Literature DB >> 19099276

[Mucocutaneous infections in immunosuppression].

P H Itin1, M Battegay.   

Abstract

The skin has several physical, chemical and immunological properties which help to protect the internal organs. In addition, there is a physiological colonisation of commensal microbes which help to suppress the expansion of pathogenic germs on the skin. Genetic or acquired immunodeficiency will have an impact to these factors. Drug induced immunodeficiency is common in organ transplanted patients with the aim to prevent organ rejection. HIV infection most commonly leads without therapy to marked immune suppression. Such patients with prolonged immunodeficiency often develop atypical manifestation of mucocutaneous infections. Therefore such patients should be biopsied liberally and besides the conventional histology a part of the biopsied tissue should be used for microbiological cultures. In addition to acute infections of the skin, long-term effects of oncogenic viruses have to be taken in account which can lead to epithelial cancers (HPV), Kaposi sarcomas (HHV8) and lymphomas (EBV). There are mucocutaneous markers for immunosuppression such as oral hairy leukoplakia, which are commonly seen in AIDS patients but may also be observed in otherwise chronically immune suppressed patients. This work gives an overview to the pathophysiology of skin protection and describes typical mucocutaneous infections in immune suppressed patients.

Entities:  

Mesh:

Year:  2009        PMID: 19099276     DOI: 10.1007/s00108-008-2207-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  16 in total

Review 1.  Chemotherapeutic agents and the skin: An update.

Authors:  Noushin Heidary; Haley Naik; Susan Burgin
Journal:  J Am Acad Dermatol       Date:  2008-04       Impact factor: 11.527

2.  Transplantation-associated malignancies: restriction of human herpes virus 8 to Kaposi's sarcoma.

Authors:  G Cathomas; M Tamm; C E McGandy; P H Itin; F Gudat; G Thiel; M J Mihatsch
Journal:  Transplantation       Date:  1997-07-15       Impact factor: 4.939

Review 3.  Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed.

Authors:  P H Itin; R Frei; S Lautenschlager; S A Buechner; C Surber; A Gratwohl; A F Widmer
Journal:  J Am Acad Dermatol       Date:  1998-09       Impact factor: 11.527

Review 4.  Skin microflora and bacterial infections of the skin.

Authors:  K Chiller; B A Selkin; G J Murakawa
Journal:  J Investig Dermatol Symp Proc       Date:  2001-12

Review 5.  Skin infections in organ transplant recipients.

Authors:  Claas Ulrich; Monika Hackethal; Thomas Meyer; Alexandra Geusau; Ingo Nindl; Martina Ulrich; Tobias Forschner; Wolfram Sterry; Eggert Stockfleth
Journal:  J Dtsch Dermatol Ges       Date:  2007-11-09       Impact factor: 5.584

6.  Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?

Authors:  Barbara Castelnuovo; Hellen Byakwaga; Joris Menten; Petra Schaefer; Moses Kamya; Robert Colebunders
Journal:  AIDS       Date:  2008-01-11       Impact factor: 4.177

7.  Immune reconstitution in HIV-infected patients.

Authors:  Hans H Hirsch; Gilbert Kaufmann; Pedram Sendi; Manuel Battegay
Journal:  Clin Infect Dis       Date:  2004-04-05       Impact factor: 9.079

8.  Prevalence and factors associated with dry skin in HIV infection: the FRAM study.

Authors:  Daniel Lee; Constance A Benson; Cora E Lewis; Carl Grunfeld; Rebecca Scherzer
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

9.  Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice.

Authors:  Karin M Aberg; Katherine A Radek; Eung-Ho Choi; Dong-Kun Kim; Marianne Demerjian; Melanie Hupe; Joseph Kerbleski; Richard L Gallo; Tomas Ganz; Theodora Mauro; Kenneth R Feingold; Peter M Elias
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

10.  Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

Authors: 
Journal:  Lancet       Date:  2008-07-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.